Taylor Hall, M.S.’s Post

🎀 Keys to an effective PR campaign for Breast Cancer Awareness Month 🎀. In the context of the commemoration of the International Day against breast cancer today, and considering that October is the month of awareness, support, and action in the fight against breast cancer. As PR professionals, we have a responsibility to create campaigns that truly make a difference. Here I share some key points to make a positive impact: 1️⃣ Clear and Empathetic Messages: Sensitivity is key. Communicate the importance of early detection and support for those in need, with an optimistic and respectful tone. 2️⃣ Authenticity and Social Purpose: Campaigns must go beyond marketing. A genuine focus on education and support for the cause strengthens brand credibility. 3️⃣ Strategic Partnerships: Collaborating with experts and health organizations legitimizes actions and provides valuable resources for the public. 4️⃣ Inspirational Testimonials: Stories of survivors and specialists generate an emotional connection and give visibility to the real-life experiences behind the disease. 5️⃣ Ambassador Mobilization: Celebrities, influencers, and media can amplify the campaign message and reach a wider audience. 6️⃣ Social Media and Hashtags: Creating interactive content and using themed hashtags helps viralize the cause and encourage community participation. 7️⃣ Events and Activations: Walks, talks, and workshops are opportunities to raise awareness and funds. 8️⃣ Impactful Visual Material: The use of symbolic elements, such as the pink ribbon, reinforces the identity of the campaign and visually connects it with the cause. 9️⃣ Results Measurement: Establishing KPIs allows us to adjust strategies and measure the true impact of our actions. 🔟 Corporate Support: Involving employees and creating awareness from within is key to consolidating a solid social responsibility image. The #MonthAgainstBreastCancer reminds us that every action counts and that our communication strategies can make a difference. 💪💖 #PR #EffectiveCommunication #SocialResponsibility #FightAgainstCancer #EarlyDetection #Awareness #PublicRelations

At The Variable, we don't just create ads—we create different. Last night, our Serious Foreplay campaign with Fuck Cancer took home the Shorty Impact Award for awareness campaigns, proving that being bold can have a huge impact. Skin cancer is the most common cancer in the U.S., but it's almost 100% curable if caught early. Inspired by a team member who discovered a cancerous mole during an intimate moment, we partnered with Fuck Cancer to turn foreplay into a lifesaving act. To bring the campaign to life, we created cheeky, inclusive guides like "Reverse the Risk Cowgirl" to make skin scans fun and educational; bold videos that taught the ABCDEs of mole-checking in unforgettable ways; strategic media placements with lifestyle and adult-related content; and partnerships with sex-positive influencers and physicians. The results? ✔ Website traffic tripled ✔ Ads saw an 800% higher CTR ✔ And most importantly, lives were saved—including one of our own team members, who caught a potentially dangerous mole thanks to the campaign's message. This campaign isn't just an ad—it's a movement to make partner-aided skin checks a lifesaving routine. Huge thanks to Fuck Cancer for trusting us to help make a real difference. #wearethevariable

Our Social Media Workshop is live! Learn more about the patient caregiver experience and #BTS on the Targeting Cancer Campaign. This workshop discusses leveraging social media for awareness. Learn more about how to access our virtual sessions here: https://ow.ly/vrNs50QAgm6

NEW from #CAR-T Meeting 2024 | Targeting BAFF-R with CAR-Ts to treat #MCL 🎥 🩸 Mike Barnkob, MD, PhD, Odense University Hospital, shares insights into the development of BAFF-receptor (BAFF-R)-specific #CARs, which were investigated for the treatment of #mantlecelllymphoma (MCL) While these CARs were able to kill primary #MCL #cells, relapse did occur, and Dr Barnkob highlights possible escape mechanisms 🔦 Give it a watch to learn more 👉 https://lnkd.in/ehGZhhxc #HemOnc #Lymsm #VJHemOnc

I am excited to share our recent publication where we investigated the binding affinities of fourteen ligands from BYL719 (a PI3Kα inhibitor previously discovered at Novartis) analogs. PI3Kα is a lipid kinase that is well-known as an oncogenic target in HR+/HER2- advanced breast cancer treatment. Our study employed a variety of in-silico techniques, including AMBER TI, MMPBSA, MMGBSA, docking, and machine learning, to characterize these ligands and predict their binding affinities. The structural insights from our simulations suggest that although the ligand-hinge interaction is the primary driver of ligand stability at the pocket, the R group positioning at C2 or C6 of pyridine/pyrimidine also plays a significant role. Binding affinities predicted via TI were in good agreement with previously reported affinities. However, computationally demanding techniques such as TI might not always be the most efficient approach for affinity prediction, as in our case study fast high-throughput techniques were capable of classifying compounds as active or inactive, and one docking approach showed comparable accuracy to TI. Camilo Velez Vega Cihan Soylu #cancerresearch #drugdiscovery #computationalchemistry #novartis #drugdesign

Doing a skin check? Confidence is key & social media ads may help

Getting ready for #ASCO24? So is Real Chemistry. Check out our latest report on how the #healthcare industry can more effectively use social media to promote early #cancer screenings in young adults.

October is breast cancer awareness month. Today is the last day of October so here is a message from some WHO Fides health influencers. Remember early detection is key. Go get screened. Dr RhondaJohnson johnson Dr Camille Bowen Dr Daniele Basta Jordan Tralins Dr Anchal Agarwal Dr Sadia Mansoor Dr Mathew Okoh Health AVAIL World Health Organization #Fides #breastcancer #breastcancerawareness #getscreened #gogetscreened #breastcancerawarenessmonth

New Method Shows Promise Towards Targeting Glioblastoma https://lnkd.in/e94X5pQN

🚀 Unlock the Power of Connection at HerHealth Oncology Congress 2024 🚀 Ready to position your brand as a leader in oncology? Imagine your company at the forefront of innovation, engaging directly with over 300 top oncologists, healthcare leaders, and decision-makers. The HerHealth Oncology Congress 2024 offers a unique opportunity to showcase your brand and influence the future of cancer care. Why should you join us? 💥 Display your innovations to a highly targeted audience of industry influencers. With over 50 participating organizations and keynote speakers like Dr. Barbara McAneny, former President of the American Medical Association, this is your chance to make a lasting impression. 💥 Align your brand with the cutting edge of oncology research and treatment. Being featured alongside experts like Dr. McAneny, Dr Anita Johnson and other leaders in the field signals your commitment to advancing healthcare. 💥 Engage in meaningful conversations and form strategic partnerships that can elevate your business. Whether it’s networking with industry giants or collaborating on groundbreaking initiatives, the possibilities are endless. Special Offer: Secure your spot before September 1st and enjoy 10% off your exhibitor or sponsorship package! Don't miss out—spaces are filling up quickly. Feel the impact—envision your brand being recognized as a vital player in the oncology community. This is more than just an exhibit; it’s your platform to influence, inspire, and innovate. 📅 Dates: October 26-27, 2024 📍 Location: B Resort & Spa, Orlando, FL 🔗 Ready to make your mark? Contact us now to secure your spot and be part of this transformative event. Let’s build a healthier future together. #Oncology #HealthcareInnovation #HerHealthCongress #CancerCare #HealthcareLeadership #ExhibitorsWanted #SponsorshipOpportunities #MedicalExhibitors #HealthTech #OncologyResearch